Bambusa Therapeutics, Inc. (BBTX)

NASDAQ: BBTX · Real-Time Price · USD

17.50

+0.34 (1.98%)

Nov 12, 2026, 9:36 AM EST - Market open

Bambusa Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Selling, General & Admin	5.77	5.91	1.03
Research & Development	43.26	34.79	15.63
Operating Expenses	49.03	40.7	16.66
Operating Income	-49.03	-40.7	-16.66
Interest & Investment Income	2.75	2.17	0.16
Other Non Operating Income (Expenses)	0.09	-0.33	0.01
Pretax Income	-46.12	-38.85	-16.49
Income Tax Expense	2.58	2.23	-
Net Income	-48.7	-41.09	-16.49
Net Income to Common	-48.7	-41.09	-16.49
Net Income Growth	-	-	-
Shares Outstanding (Basic)	8	4	-
Shares Outstanding (Diluted)	8	4	-
Shares Change	-	-	-
EPS (Basic)	-6.08	-9.80	-
EPS (Diluted)	-6.08	-9.80	-
EPS Growth	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
EBIT	-49.03	-40.7	-16.66

SEC Filings: 10-K · 10-Q